1. Alexion says “no” to investor proactive sale demand — FDA approves first copycats of Novartis MS drug Gilenya — $178M stockpile of Merck ebola vaccine authorized — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Pathnostics

Anonymous board for Pathnostics

Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    0
    Views:
    2,368
  2. anonymous
    Replies:
    0
    Views:
    1,953
  3. anonymous
    Replies:
    1
    Views:
    2,819

Thread Display Options

Loading...